La mia nuova descrizione qui!
Price of a print issue €25.00
AIM: To evaluate the results of synchronous pancreas and liver resection in patients with metastatic carcinoma accompanied
by peritoneal carcinomatosis (PC) who underwent cytoreductive surgery (CRS)/hyperthermic intraperitoneal
MATERIAL AND METHODS: Overall, 35 patients with PC who underwent CRS/HIPEC at Umraniye Education and
Research Hospital owing to different etiological causes were evaluated for operation procedure, age, sex, comorbid diseases,
ASA score, systemic chemo/radiotherapy, duration of surgery, chemotherapy (CT) protocol applied in HIPEC, amount
of bleeding, synchronous hepatobiliary resection interventions during operation and short/long-term mortality and morbidity.
RESULTS: Fifteen patients were male and 20 were female. Mean age was 58.375 ± 13.02 (range, 27–85) years.
CRS/HIPEC was performed in 12 patients (34.3%), whereas only CRS was performed in 23 (65.7%) patients. The
lowest and highest perioperative bleeding amount was 50 cc and 2000 cc, respectively, and 6 (17.1%) patients had
intraoperative bleeding of ≥1000 cc. Synchronous isolated pancreatic resection, hepatic + pancreatic resection and isolated
liver resection was performed in 3 (8.6%), 5 (14.3%) and 27 (77.1%) patients treated with CRS/HIPEC. Two
patients died within postoperative day 30, and the mortality rate was 5.7%.
CONCLUSION: Hepatopancreatobiliary surgery is a difficult intervention and is associated with serious morbidities.
Synchronisation of hepatopancreatobiliary surgery with CRS/HIPEC may be challenging for the surgeon and clinician.
Here we emphasise that this combination can be performed safely by an experienced team with a multidisciplinary
approach and good patient preparation.